{
    "table_name": "PLATFORM.KNOWNDRUGSAGGREGATED",
    "table_fullname": "OPEN_TARGETS_PLATFORM_1.PLATFORM.KNOWNDRUGSAGGREGATED",
    "column_names": [
        "prefName",
        "status",
        "mechanismOfAction",
        "urls",
        "targetId",
        "ancestors",
        "tradeNames",
        "diseaseId",
        "synonyms",
        "label",
        "drugId",
        "phase",
        "targetName",
        "approvedSymbol",
        "approvedName",
        "drugType",
        "targetClass"
    ],
    "column_types": [
        "TEXT",
        "TEXT",
        "TEXT",
        "VARIANT",
        "TEXT",
        "VARIANT",
        "VARIANT",
        "TEXT",
        "VARIANT",
        "TEXT",
        "TEXT",
        "FLOAT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "VARIANT"
    ],
    "description": [
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null,
        null
    ],
    "sample_rows": [
        {
            "drugId": "CHEMBL409",
            "targetId": "ENSG00000169083",
            "diseaseId": "MONDO_0008315",
            "phase": 2.0,
            "status": "Recruiting",
            "urls": "{\n  \"list\": [\n    {\n      \"element\": {\n        \"niceName\": \"ClinicalTrials\",\n        \"url\": \"https://clinicaltrials.gov/study/NCT04025372\"\n      }\n    },\n    {\n      \"element\": {\n        \"niceName\": \"ClinicalTrials\",\n        \"url\": \"https://clinicaltrials.gov/study/NCT04734730\"\n      }\n    },\n    {\n      \"element\": {\n        \"niceName\": \"ClinicalTrials\",\n        \"url\": \"https://clinicaltrials.gov/study/NCT03541928\"\n      }\n    }\n  ]\n}",
            "ancestors": "{\n  \"list\": [\n    {\n      \"element\": \"OTAR_0000017\"\n    },\n    {\n      \"element\": \"EFO_0009555\"\n    },\n    {\n      \"element\": \"EFO_0007355\"\n    },\n    {\n      \"element\": \"MONDO_0024582\"\n    },\n    {\n      \"element\": \"MONDO_0002149\"\n    },\n    {\n      \"element\": \"MONDO_0023370\"\n    },\n    {\n      \"element\": \"EFO_1000051\"\n    },\n    {\n      \"element\": \"EFO_0009602\"\n    },\n    {\n      \"element\": \"MONDO_0045024\"\n    },\n    {\n      \"element\": \"MONDO_0021259\"\n    },\n    {\n      \"element\": \"MONDO_0004992\"\n    },\n    {\n      \"element\": \"EFO_0000512\"\n    },\n    {\n      \"element\": \"EFO_0000616\"\n    }\n  ]\n}",
            "label": "prostate cancer",
            "approvedSymbol": "AR",
            "approvedName": "androgen receptor",
            "targetClass": "{\n  \"list\": [\n    {\n      \"element\": \"Transcription factor\"\n    },\n    {\n      \"element\": \"Unclassified protein\"\n    }\n  ]\n}",
            "prefName": "BICALUTAMIDE",
            "tradeNames": "{\n  \"list\": [\n    {\n      \"element\": \"Bicalutamide\"\n    },\n    {\n      \"element\": \"Calutide\"\n    },\n    {\n      \"element\": \"Casodex\"\n    },\n    {\n      \"element\": \"Cosudex\"\n    },\n    {\n      \"element\": \"Kalumid\"\n    }\n  ]\n}",
            "synonyms": "{\n  \"list\": [\n    {\n      \"element\": \"Bicalutamide\"\n    },\n    {\n      \"element\": \"Casodex\"\n    },\n    {\n      \"element\": \"ICI 176,334\"\n    },\n    {\n      \"element\": \"ICI-176334\"\n    },\n    {\n      \"element\": \"ICI176,334-1\"\n    },\n    {\n      \"element\": \"NSC-759816\"\n    }\n  ]\n}",
            "drugType": "Small molecule",
            "mechanismOfAction": "Androgen Receptor antagonist",
            "targetName": "Androgen Receptor"
        },
        {
            "drugId": "CHEMBL409",
            "targetId": "ENSG00000169083",
            "diseaseId": "EFO_0000305",
            "phase": 2.0,
            "status": "Active, not recruiting",
            "urls": "{\n  \"list\": [\n    {\n      \"element\": {\n        \"niceName\": \"ClinicalTrials\",\n        \"url\": \"https://clinicaltrials.gov/study/NCT03650894\"\n      }\n    }\n  ]\n}",
            "ancestors": "{\n  \"list\": [\n    {\n      \"element\": \"OTAR_0000017\"\n    },\n    {\n      \"element\": \"MONDO_0021350\"\n    },\n    {\n      \"element\": \"MONDO_0000653\"\n    },\n    {\n      \"element\": \"MONDO_0023370\"\n    },\n    {\n      \"element\": \"MONDO_0007254\"\n    },\n    {\n      \"element\": \"MONDO_0045024\"\n    },\n    {\n      \"element\": \"MONDO_0004992\"\n    },\n    {\n      \"element\": \"EFO_0009483\"\n    },\n    {\n      \"element\": \"MONDO_0003274\"\n    },\n    {\n      \"element\": \"EFO_0003869\"\n    },\n    {\n      \"element\": \"EFO_0000313\"\n    },\n    {\n      \"element\": \"EFO_0010285\"\n    },\n    {\n      \"element\": \"EFO_0006858\"\n    },\n    {\n      \"element\": \"EFO_0000616\"\n    }\n  ]\n}",
            "label": "breast carcinoma",
            "approvedSymbol": "AR",
            "approvedName": "androgen receptor",
            "targetClass": "{\n  \"list\": [\n    {\n      \"element\": \"Transcription factor\"\n    },\n    {\n      \"element\": \"Unclassified protein\"\n    }\n  ]\n}",
            "prefName": "BICALUTAMIDE",
            "tradeNames": "{\n  \"list\": [\n    {\n      \"element\": \"Bicalutamide\"\n    },\n    {\n      \"element\": \"Calutide\"\n    },\n    {\n      \"element\": \"Casodex\"\n    },\n    {\n      \"element\": \"Cosudex\"\n    },\n    {\n      \"element\": \"Kalumid\"\n    }\n  ]\n}",
            "synonyms": "{\n  \"list\": [\n    {\n      \"element\": \"Bicalutamide\"\n    },\n    {\n      \"element\": \"Casodex\"\n    },\n    {\n      \"element\": \"ICI 176,334\"\n    },\n    {\n      \"element\": \"ICI-176334\"\n    },\n    {\n      \"element\": \"ICI176,334-1\"\n    },\n    {\n      \"element\": \"NSC-759816\"\n    }\n  ]\n}",
            "drugType": "Small molecule",
            "mechanismOfAction": "Androgen Receptor antagonist",
            "targetName": "Androgen Receptor"
        },
        {
            "drugId": "CHEMBL409",
            "targetId": "ENSG00000169083",
            "diseaseId": "MONDO_0007254",
            "phase": 2.0,
            "status": "Unknown status",
            "urls": "{\n  \"list\": [\n    {\n      \"element\": {\n        \"niceName\": \"ClinicalTrials\",\n        \"url\": \"https://clinicaltrials.gov/study/NCT02910050\"\n      }\n    }\n  ]\n}",
            "ancestors": "{\n  \"list\": [\n    {\n      \"element\": \"EFO_0003869\"\n    },\n    {\n      \"element\": \"OTAR_0000017\"\n    },\n    {\n      \"element\": \"MONDO_0021350\"\n    },\n    {\n      \"element\": \"MONDO_0000653\"\n    },\n    {\n      \"element\": \"MONDO_0023370\"\n    },\n    {\n      \"element\": \"MONDO_0045024\"\n    },\n    {\n      \"element\": \"MONDO_0004992\"\n    },\n    {\n      \"element\": \"EFO_0010285\"\n    },\n    {\n      \"element\": \"EFO_0009483\"\n    },\n    {\n      \"element\": \"MONDO_0003274\"\n    },\n    {\n      \"element\": \"EFO_0000616\"\n    }\n  ]\n}",
            "label": "breast cancer",
            "approvedSymbol": "AR",
            "approvedName": "androgen receptor",
            "targetClass": "{\n  \"list\": [\n    {\n      \"element\": \"Transcription factor\"\n    },\n    {\n      \"element\": \"Unclassified protein\"\n    }\n  ]\n}",
            "prefName": "BICALUTAMIDE",
            "tradeNames": "{\n  \"list\": [\n    {\n      \"element\": \"Bicalutamide\"\n    },\n    {\n      \"element\": \"Calutide\"\n    },\n    {\n      \"element\": \"Casodex\"\n    },\n    {\n      \"element\": \"Cosudex\"\n    },\n    {\n      \"element\": \"Kalumid\"\n    }\n  ]\n}",
            "synonyms": "{\n  \"list\": [\n    {\n      \"element\": \"Bicalutamide\"\n    },\n    {\n      \"element\": \"Casodex\"\n    },\n    {\n      \"element\": \"ICI 176,334\"\n    },\n    {\n      \"element\": \"ICI-176334\"\n    },\n    {\n      \"element\": \"ICI176,334-1\"\n    },\n    {\n      \"element\": \"NSC-759816\"\n    }\n  ]\n}",
            "drugType": "Small molecule",
            "mechanismOfAction": "Androgen Receptor antagonist",
            "targetName": "Androgen Receptor"
        },
        {
            "drugId": "CHEMBL409",
            "targetId": "ENSG00000169083",
            "diseaseId": "EFO_0003869",
            "phase": 2.0,
            "status": "Recruiting",
            "urls": "{\n  \"list\": [\n    {\n      \"element\": {\n        \"niceName\": \"ClinicalTrials\",\n        \"url\": \"https://clinicaltrials.gov/study/NCT06365788\"\n      }\n    }\n  ]\n}",
            "ancestors": "{\n  \"list\": [\n    {\n      \"element\": \"OTAR_0000017\"\n    },\n    {\n      \"element\": \"MONDO_0021350\"\n    },\n    {\n      \"element\": \"MONDO_0023370\"\n    },\n    {\n      \"element\": \"MONDO_0045024\"\n    },\n    {\n      \"element\": \"EFO_0010285\"\n    },\n    {\n      \"element\": \"EFO_0009483\"\n    },\n    {\n      \"element\": \"EFO_0000616\"\n    }\n  ]\n}",
            "label": "breast neoplasm",
            "approvedSymbol": "AR",
            "approvedName": "androgen receptor",
            "targetClass": "{\n  \"list\": [\n    {\n      \"element\": \"Transcription factor\"\n    },\n    {\n      \"element\": \"Unclassified protein\"\n    }\n  ]\n}",
            "prefName": "BICALUTAMIDE",
            "tradeNames": "{\n  \"list\": [\n    {\n      \"element\": \"Bicalutamide\"\n    },\n    {\n      \"element\": \"Calutide\"\n    },\n    {\n      \"element\": \"Casodex\"\n    },\n    {\n      \"element\": \"Cosudex\"\n    },\n    {\n      \"element\": \"Kalumid\"\n    }\n  ]\n}",
            "synonyms": "{\n  \"list\": [\n    {\n      \"element\": \"Bicalutamide\"\n    },\n    {\n      \"element\": \"Casodex\"\n    },\n    {\n      \"element\": \"ICI 176,334\"\n    },\n    {\n      \"element\": \"ICI-176334\"\n    },\n    {\n      \"element\": \"ICI176,334-1\"\n    },\n    {\n      \"element\": \"NSC-759816\"\n    }\n  ]\n}",
            "drugType": "Small molecule",
            "mechanismOfAction": "Androgen Receptor antagonist",
            "targetName": "Androgen Receptor"
        },
        {
            "drugId": "CHEMBL409",
            "targetId": "ENSG00000169083",
            "diseaseId": "EFO_0000673",
            "phase": 3.0,
            "status": "Terminated",
            "urls": "{\n  \"list\": [\n    {\n      \"element\": {\n        \"niceName\": \"ClinicalTrials\",\n        \"url\": \"https://clinicaltrials.gov/study/NCT00514917\"\n      }\n    }\n  ]\n}",
            "ancestors": "{\n  \"list\": [\n    {\n      \"element\": \"OTAR_0000017\"\n    },\n    {\n      \"element\": \"MONDO_0024276\"\n    },\n    {\n      \"element\": \"EFO_0009555\"\n    },\n    {\n      \"element\": \"EFO_0007355\"\n    },\n    {\n      \"element\": \"MONDO_0024582\"\n    },\n    {\n      \"element\": \"MONDO_0002149\"\n    },\n    {\n      \"element\": \"MONDO_0023370\"\n    },\n    {\n      \"element\": \"EFO_1000051\"\n    },\n    {\n      \"element\": \"EFO_0009602\"\n    },\n    {\n      \"element\": \"MONDO_0045024\"\n    },\n    {\n      \"element\": \"MONDO_0021259\"\n    },\n    {\n      \"element\": \"MONDO_0004992\"\n    },\n    {\n      \"element\": \"MONDO_0008315\"\n    },\n    {\n      \"element\": \"EFO_0000512\"\n    },\n    {\n      \"element\": \"EFO_0000313\"\n    },\n    {\n      \"element\": \"EFO_0000228\"\n    },\n    {\n      \"element\": \"EFO_0001663\"\n    },\n    {\n      \"element\": \"EFO_0006858\"\n    },\n    {\n      \"element\": \"EFO_0000616\"\n    }\n  ]\n}",
            "label": "prostate adenocarcinoma",
            "approvedSymbol": "AR",
            "approvedName": "androgen receptor",
            "targetClass": "{\n  \"list\": [\n    {\n      \"element\": \"Transcription factor\"\n    },\n    {\n      \"element\": \"Unclassified protein\"\n    }\n  ]\n}",
            "prefName": "BICALUTAMIDE",
            "tradeNames": "{\n  \"list\": [\n    {\n      \"element\": \"Bicalutamide\"\n    },\n    {\n      \"element\": \"Calutide\"\n    },\n    {\n      \"element\": \"Casodex\"\n    },\n    {\n      \"element\": \"Cosudex\"\n    },\n    {\n      \"element\": \"Kalumid\"\n    }\n  ]\n}",
            "synonyms": "{\n  \"list\": [\n    {\n      \"element\": \"Bicalutamide\"\n    },\n    {\n      \"element\": \"Casodex\"\n    },\n    {\n      \"element\": \"ICI 176,334\"\n    },\n    {\n      \"element\": \"ICI-176334\"\n    },\n    {\n      \"element\": \"ICI176,334-1\"\n    },\n    {\n      \"element\": \"NSC-759816\"\n    }\n  ]\n}",
            "drugType": "Small molecule",
            "mechanismOfAction": "Androgen Receptor antagonist",
            "targetName": "Androgen Receptor"
        }
    ]
}